Journal
RSC ADVANCES
Volume 10, Issue 8, Pages 4529-4537Publisher
ROYAL SOC CHEMISTRY
DOI: 10.1039/c9ra09028b
Keywords
-
Categories
Funding
- National Key Research and Development Program of China [2017YFC1702006]
- Dalian Science and Technology Innovation Foundation [2018J13SN114]
Ask authors/readers for more resources
Due to their association with type 2 diabetes mellitus treatment, alpha-glucosidase inhibitors have attracted increasing attention of researchers. In this study, we systemically investigated the kinetics and inhibition mechanism of piceatannol on alpha-glucosidase. Enzyme kinetics analyses showed that piceatannol exhibited strong inhibition on alpha-glucosidase in a non-competitive manner. Spectroscopy analyses indicated that piceatannol could bind with alpha-glucosidase to form complexes via high affinity. Further, computational molecular dynamics and molecular docking studies validated that the binding of piceatannol was outside the catalytic site of alpha-glucosidase, which would induce conformational changes of alpha-glucosidase and block the entrance of substrate, causing declines in alpha-glucosidase activities. Our results provide useful information not only for the inhibition mechanism of piceatannol against alpha-glucosidase but also for a novel target site for developing novel alpha-glucosidase inhibitors as potential therapeutic agents in the treatment of type 2 diabetes mellitus.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available